SundrugLtd Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 4/6

SundrugLtd yıllık ortalama 3.6% oranında kazançlarını artırırken, Consumer Retailing sektöründe kazançlar growing at 8.9% annual. Gelirler growing yılda ortalama 4.9% oranında artmaktadır. SundrugLtd'in özkaynak karlılığı 11.3% ve net marjı 3.8%'dir.

Anahtar bilgiler

3.6%

Kazanç büyüme oranı

3.6%

EPS büyüme oranı

Consumer Retailing Sektör Büyümesi	7.8%
Gelir büyüme oranı	4.9%
Özkaynak getirisi	11.3%
Net Marj	3.8%
Son Kazanç Güncellemesi	30 Sep 2024

Yakın geçmiş performans güncellemeleri

Recent updates

Here's Why We Think SundrugLtd (TSE:9989) Is Well Worth Watching

Nov 18

Investors Could Be Concerned With SundrugLtd's (TSE:9989) Returns On Capital

Nov 05

Sundrug Co.,Ltd.'s (TSE:9989) Intrinsic Value Is Potentially 31% Above Its Share Price

Sep 25

Analyst Estimates: Here's What Brokers Think Of Sundrug Co.,Ltd. (TSE:9989) After Its Yearly Report

Jun 28

SundrugLtd (TSE:9989) Ticks All The Boxes When It Comes To Earnings Growth

Jun 06

Sundrug Co.,Ltd.'s (TSE:9989) Share Price Not Quite Adding Up

May 11

Be Wary Of SundrugLtd (TSE:9989) And Its Returns On Capital

Apr 10

SundrugLtd (TSE:9989) Will Pay A Dividend Of ¥57.00

Mar 11

Gelir ve Gider Dağılımı

SundrugLtd nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.

Kazanç ve Gelir Geçmişi

TSE:9989 Gelir, gider ve kazançlar (JPY Millions )
Tarih	Gelir	Kazançlar	G+A Giderleri
30 Sep 24	775,655	29,342	139,425
30 Jun 24	764,196	29,516	136,228
31 Mar 24	751,777	29,126	133,311
31 Dec 23	736,881	28,120	145,662
30 Sep 23	722,946	27,035	143,150
30 Jun 23	706,153	26,305	138,860
31 Mar 23	690,462	25,703	134,495
31 Dec 22	676,628	25,213	129,441
30 Sep 22	661,203	24,120	125,708
30 Jun 22	650,992	23,350	123,748
31 Mar 22	648,734	23,853	122,454
31 Dec 21	645,191	23,608	121,766
30 Sep 21	644,605	24,306	122,233
30 Jun 21	641,667	25,079	122,183
31 Mar 21	634,310	25,329	120,879
31 Dec 20	634,169	25,423	119,918
30 Sep 20	617,407	23,638	118,069
30 Jun 20	622,197	24,200	117,552
31 Mar 20	617,769	23,692	117,996
31 Dec 19	607,565	24,564	116,270
30 Sep 19	612,185	25,742	115,241
30 Jun 19	594,960	24,342	113,283
31 Mar 19	588,069	23,933	111,671
31 Dec 18	583,085	24,288	110,398
30 Sep 18	578,241	24,554	108,759
30 Jun 18	571,724	24,948	106,650
31 Mar 18	564,215	24,829	104,620
31 Dec 17	555,031	24,590	102,601
30 Sep 17	546,370	24,155	100,582
30 Jun 17	536,737	23,684	98,425
31 Mar 17	528,394	23,312	96,507
31 Dec 16	524,155	22,684	95,348
30 Sep 16	517,289	22,216	93,739
30 Jun 16	511,786	22,207	92,456
31 Mar 16	503,773	21,569	90,867
31 Dec 15	492,036	20,881	88,687
30 Sep 15	480,933	19,971	86,985
30 Jun 15	466,704	18,056	84,714
31 Mar 15	445,818	16,362	82,168
31 Dec 14	449,548	15,122	80,870
30 Sep 14	442,504	14,389	78,936
30 Jun 14	440,575	15,167	77,781
31 Mar 14	447,819	15,754	77,500
31 Dec 13	431,272	16,335	75,547

Kaliteli Kazançlar: 9989 yüksek kaliteli kazançlar sağlıyor.

Büyüyen Kar Marjı: 9989 'nin mevcut net kar marjları (3.8%) geçen yılın (3.7%) sinden daha yüksektir.

Serbest Nakit Akışı ve Kazanç Analizi

Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: 9989 şirketinin kazancı son 5 yılda yılda 3.6% oranında arttı.

Büyüme Hızlandırma: 9989 'un son bir yıldaki kazanç büyümesi ( 8.5% ) 5 yıllık ortalamasını (yıllık 3.6% ) aşıyor.

Kazançlar vs. Sektör: 9989 geçen yılki kazanç büyümesi ( 8.5% ) Consumer Retailing sektörünün 12.3% performansını geride bırakmadı.

Özkaynak Getirisi

Yüksek ROE: 9989 'nin Özsermaye Getirisi ( 11.3% ) düşük olarak değerlendiriliyor.

SundrugLtd Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 4/6

Anahtar bilgiler

Yakın geçmiş performans güncellemeleri

Second quarter 2025 earnings: EPS misses analyst expectations

Sundrug Co.,Ltd. to Report Q2, 2025 Results on Nov 14, 2024

First quarter 2025 earnings: EPS exceeds analyst expectations

Full year 2024 earnings: EPS exceeds analyst expectations

Sundrug Co.,Ltd. to Report Q1, 2025 Results on Aug 14, 2024

Full year 2024 earnings: EPS exceeds analyst expectations

Recent updates

Second quarter 2025 earnings: EPS misses analyst expectations

Here's Why We Think SundrugLtd (TSE:9989) Is Well Worth Watching

Investors Could Be Concerned With SundrugLtd's (TSE:9989) Returns On Capital

Sundrug Co.,Ltd.'s (TSE:9989) Intrinsic Value Is Potentially 31% Above Its Share Price

Upcoming dividend of JP¥65.00 per share

Sundrug Co.,Ltd.'s (TSE:9989) Business Is Yet to Catch Up With Its Share Price

SundrugLtd's (TSE:9989) Upcoming Dividend Will Be Larger Than Last Year's

Sundrug Co.,Ltd. to Report Q2, 2025 Results on Nov 14, 2024

First quarter 2025 earnings: EPS exceeds analyst expectations

SundrugLtd (TSE:9989) Will Pay A Larger Dividend Than Last Year At ¥65.00

SundrugLtd (TSE:9989) Will Pay A Larger Dividend Than Last Year At ¥65.00

Final dividend increased to JP¥65.00

Analyst Estimates: Here's What Brokers Think Of Sundrug Co.,Ltd. (TSE:9989) After Its Yearly Report

Full year 2024 earnings: EPS exceeds analyst expectations

SundrugLtd (TSE:9989) Ticks All The Boxes When It Comes To Earnings Growth

Sundrug Co.,Ltd. to Report Q1, 2025 Results on Aug 14, 2024

Full year 2024 earnings: EPS exceeds analyst expectations

Sundrug Co.,Ltd., Annual General Meeting, Jun 21, 2024

Sundrug Co.,Ltd.'s (TSE:9989) Share Price Not Quite Adding Up

Be Wary Of SundrugLtd (TSE:9989) And Its Returns On Capital

Now 21% overvalued after recent price rise

Upcoming dividend of JP¥57.00 per share

SundrugLtd (TSE:9989) Will Pay A Dividend Of ¥57.00

Now 20% overvalued after recent price rise

Sundrug Co.,Ltd. to Report Fiscal Year 2024 Results on May 15, 2024

Third quarter 2024 earnings: Revenues and EPS in line with analyst expectations

Sundrug Co.,Ltd. to Report Q3, 2024 Results on Feb 14, 2024

Second quarter 2024 earnings: EPS and revenues exceed analyst expectations

Upcoming dividend of JP¥57.00 per share at 2.7% yield

Sundrug Co.,Ltd. to Report Q2, 2024 Results on Nov 14, 2023

First quarter 2024 earnings released: EPS: JP¥59.01 (vs JP¥53.86 in 1Q 2023)

Sundrug Co.,Ltd. to Report Q1, 2024 Results on Aug 10, 2023

Sundrug Co.,Ltd., Annual General Meeting, Jun 23, 2023

Full year 2023 earnings: EPS exceeds analyst expectations

Upcoming dividend of JP¥50.00 per share at 2.8% yield

Third quarter 2023 earnings released: EPS: JP¥65.36 (vs JP¥56.01 in 3Q 2022)

Sundrug Co.,Ltd. to Report Q3, 2023 Results on Feb 14, 2023

No independent directors

Upcoming dividend of JP¥50.00 per share

Sundrug Co.,Ltd. (TSE:9989) agreed to acquire Daiya, K.K. from Shintaro Ito, Ichiban Co., Ltd and others.

Sundrug Co.,Ltd. to Report Q2, 2023 Results on Nov 14, 2022

First quarter 2023 earnings released: EPS: JP¥53.86 (vs JP¥58.18 in 1Q 2022)

Sundrug Co.,Ltd. to Report Q1, 2023 Results on Aug 12, 2022

Full year 2022 earnings: EPS misses analyst expectations

Sundrug Co.,Ltd., Annual General Meeting, Jun 25, 2022

No independent directors

Sundrug Co.,Ltd. to Report Fiscal Year 2022 Results on May 13, 2022

Upcoming dividend of JP¥35.00 per share

Third quarter 2022 earnings: EPS in line with expectations, revenues disappoint

Second quarter 2022 earnings released: EPS JP¥48.36 (vs JP¥54.98 in 2Q 2021)

Upcoming dividend of JP¥35.00 per share

First quarter 2022 earnings released: EPS JP¥58.18 (vs JP¥60.32 in 1Q 2021)

Full year 2021 earnings released: EPS JP¥217 (vs JP¥203 in FY 2020)

Upcoming dividend of JP¥35.00 per share

Sundrug Co.,Ltd. to Report Fiscal Year 2021 Results on May 14, 2021

New 90-day low: JP¥4,020

Third quarter 2021 earnings released: EPS JP¥61.99 (vs JP¥46.72 in 3Q 2020)

Revenue and earnings miss expectations

New 90-day high: JP¥4,515

Sundrug Co.,Ltd. to Report Q3, 2021 Results on Feb 10, 2021

Sundrug Co.,Ltd. to Report Q2, 2021 Results on Nov 11, 2020

Gelir ve Gider Dağılımı

Kazanç ve Gelir Geçmişi

Serbest Nakit Akışı ve Kazanç Analizi

Geçmiş Kazanç Büyüme Analizi

Özkaynak Getirisi

Varlık Getirisi

Kullanılan Sermaye Getirisi

Geçmişte güçlü performans gösteren şirketleri keşfedin